My research focuses on identifying novel life-style, biochemical and genetic determinants of brain health, which in turn can serve as disease biomarkers as well as targets for intervention to reduce the burden of cognitive impairment, dementia and stroke.

1. Weinstein G, Green MS, Keinan-Boker L. (2007). Routine screening mammography in women older than 74 years: a review of the available data. Maturiatas, 57, 109-119.
2. Weinstein G, Goldbourt U, Tanne D. (2012). Body Height and Late-Life Cognition among Patients with Atherothrombotic Disease. Alzheimer’s Disease and Associated Disorders, 27, 145-152.
3. Weinstein G, Wolf PA, Beiser AS, Au R, Seshadri S. (2012). Risk Estimations, Risk Factors, and Genetic Variants Associated with Alzheimer's Disease in Selected Publications from the Framingham Heart Study. Journal of Alzheimer’s Disease, 33 Suppl 1:S439-445.
4. Weinstein G, Beiser AS, Au R, DeCarli C, Wolf PA, Seshadri S. (2013). Association of Parental Stroke with Brain Injury and Cognitive Measures in Offspring – The Framingham Heart Study. Stroke, 44, 812-815.
5. Weinstein G, Beiser AS, DeCarli C, Au R, Wolf PA, Seshadri S. (2013). Brain Imaging and Cognitive Predictors of Stroke and Alzheimer Disease in the Framingham Heart Study. Stroke, 4, 2787-2794.
6. Weinstein G, Seshadri S. (2014). Circulating biomarkers that predict incident dementia. Alzheimer's Research & Therapy, 21, 6.
7. Weinstein G, Beiser AS, Preis RS, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, Vasan RS, Seshadri S. (2014). Serum Brain-Derived Neurotrophic Factor and Risk of Dementia: The Framingham Heart Study. JAMA Neurology, 71, 55-61.
8. Weinstein G, Seshadri S. Serum brain-derived neurotrophic factor as a predictor of incident dementia-reply. (2014). JAMA Neurology, 71, 653-654.
9. Weinstein G, Goldbourt U, Tanne D (2015). Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment. Alzheimer’s Disease & Associated Disorders,29, 6-11.
10. Williams SR, Yang Q, Chen F, Liu X, Keene K, Jacques P, Chen W, Weinstein G, Hsu F, Beiser A, Wang L, Bookman E, Doheny KF, Wolf PA, Zilka M, Selhub J, Nelson S, Worrall BB, Seshadri S, Sale MM. The Genomics and Randomized Trials Network and the Framingham Heart Study (2014). Genome-wide meta-analysis of homocysteine metabolism identifies five loci and an association of ALDH1L1 with ischemic stroke. PLoS Genetics, 10, e1004214.
11. Davies G, Armstrong N, Bis JC, Bressler J, Chouraki V, Giddaluru S, Hofer E, Ibrahim-Verbaas CA, Kirin M, Lahti J, van der Lee SJ, Le Hellard S, Liu T, Marioni RE, Oldmeadow C, Postmus I, Smith AV, Smith JA, Thalamuthu A, Thomson R, Vitart V, Wang J, Yu L, Zgaga L, Zhao W, Boxall R, Harris SE, Hill WD, Liewald DC, Luciano M, Adams H, Ames D, Amin N, Amouyel P, Assareh AA, Au R, Becker JT, Beiser A, Berr C, Bertram L, Boerwinkle E, Buckley BM, Campbell H, Corley J, De Jager PL, Dufouil C, Eriksson JG, Espeseth T, Faul JD, Ford I, Scotland G, Gottesman RF, Griswold ME, Gudnason V, Harris TB, Heiss G, Hofman A, Holliday EG, Huffman J, Kardia SL, Kochan N, Knopman DS, Kwok JB, Lambert JC, Lee T, Li G, Li SC, Loitfelder M, Lopez OL, Lundervold AJ, Lundqvist A, Mather KA, Mirza SS, Nyberg L, Oostra BA, Palotie A, Papenberg G, Pattie A, Petrovic K, Polasek O, Psaty BM, Redmond P, Reppermund S, Rotter JI, Schmidt H, Schuur M, Schofield PW, Scott RJ, Steen VM, Stott DJ, van Swieten JC, Taylor KD, Trollor J, Trompet S, Uitterlinden AG, Weinstein G, Widen E, Windham BG, Jukema JW, Wright AF, Wright MJ, Yang Q, Amieva H, Attia JR, Bennett DA, Brodaty H, de Craen AJ, Hayward C, Ikram MA, Lindenberger U, Nilsson LG, Porteous DJ, Räikkönen K, Reinvang I, Rudan I, Sachdev PS, Schmidt R, Schofield PR, Srikanth V, Starr JM, Turner ST, Weir DR, Wilson JF, van Duijn C, Launer L, Fitzpatrick AL, Seshadri S, Mosley TH Jr, Deary IJ. (2015). Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Molecular Psychiatry, 20(2), 183-192.
12. Chouraki V, Beiser AS, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S. (2015). Plasma amyloid β and risk of Alzheimer's disease in the Framingham Heart Study. Alzheimers & Dementia, 11(3), 249-257.
13. Weinstein G, Preis SR, Beiser AS, Au R, Kelly-Hayes M, Kase CS, Wolf PA, Seshadri S. (2014). Cognitive Performance after Stroke – The Framingham Heart Study. International Journal of Stroke, 9 Suppl A100, 48-54.
14. Haratz S, Weinstein G, Molshazki N, Schnaider Beeri M, Ravona-Springer R, Goldbourt U, Tanne D. (2015). Impaired Cerebral Hemodynamics and Cognitive Performance in Patients with Atherothrombotic Disease. Journal of Alzheimer’s Disease, 46(1), 137-144.
15. Chauhan G, Adams HH, Bis JC, Weinstein G, Yu L, Töglhofer AM, Smith AV, van der Lee S, Gottesman RF, Thomson R, Wang J, Yang Q, Niessen WJ, Lopez OL, Becker JT, Phan TG, Beare RJ, Arfanakis K, Fleischman D, Vernooij MW, Mazoyer B, Schmidt H, Srikanth V, Knopman DS, Jack CR, Jr., Amouyel P, Hofman A, DeCarli C, Tzourio C, van Duijn CM, Bennett DA, Schmidt R, Longstreth WT, Jr., Mosley TH, Fornage M, Launer LJ, Seshadri S, Ikram MA, Debette S. (2015). Association of Alzheimer disease GWAS loci with MRI-markers of brain aging. Neurobioly of Aging, 36(4), 1765.e7-16.
16. Molshatzki N, Weinstein G, Streifler JY, Goldbourt U, Tanne D. (2015). Serum Uric Acid and Cognitive Performance in Patients with Pre-existing Atherosclerotic Disease. PLoS One, 10(3), e0120862.
17. Weinstein G, Maillard P, Himali JJ, Beiser AS, Au R, Wolf PA, Seshadri S, Decarli C. (2015). Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology, 84(23), 2329-2337.
18. Camargo EC,¹ Weinstein G,¹ Beiser A, Tan ZS, DeCarli C, Kelly-Hayes M, Kase C, Murabito JM, Seshadri S. Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study. (2016). ¹shared 1st authorship. Journal of Alzheimers Disease, 14, 53(4):1597-1608.
19. Weinstein G, Beiser AS, Preisa SR, Courchesnea P, Chourakia V, Levy D, Seshadri S (2016). Plasma clusterin levels and risk of dementia, Alzheimer’s disease and stroke. Alzheimer’s & Dementia (Amst), 3, 103-109.
20. Weinstein G (2016). Childhood conditions and current physical performance among non-institutionalized individuals aged 50+ in Israel. European Journal of Ageing, 13(4), 335-347.
21. Weinstein G, Preis SR, Beiser AS, Kaess B, Chen TC, Satizabal CL, Rahman F, Benjamin EJ, Ramachandran VS, Seshadri S (2017). Clinical and Environmental Correlates of Serum BDNF: A descriptive study with plausible implications for AD research. Current Alzheimer’s Research, 14(7):722-730.
22. Weinstein G, Lutski M, Goldbourt U, Tanne D (2017). C-reactive protein is related to future cognitive impairment and decline in elderly with cardiovascular disease. Archives of Gerontology and Geriatrics, 69:31-37.
23. Lutski M, Weinstein G, Goldbourt U, and Tanne D (2017). Insulin resistance and future cognitive performance and cognitive decline in elderly patients with cardiovascular disease. Journal of Alzheimer’s Disease, 57(2):633-643.
24. Salinas J, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, Weinstein G, Berkman LF, Rosand J, Seshadri S (2017). Associations between social relationship measures, serum brain-derived neurotrophic factor, and risk of stroke and dementia. Alzheimer’s & Dementia (N Y), 3(2):229-237.
25. Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG,Lossi L, Malojcic B, Mehrabian S, Merighi A, Mukaetova-Ladinska EB, Paraskevas G, Popescu BO, Ravid R, Traykov L, Tsivgoulis G, Weinstein G, Korczyn A, Bjerke M, Rosenberg G (2017). Biochemical markers in Vascular Cognitive Impairment associated with Subcortical Small Vessel Disease – A Consensus Report. BMC Neurology, 17(1):102.
26. Chouraki V, Preis SR, Yang, Q, Beiser A, Li S, Larson MG, Weinstein G, Wang TJ, Gerszten RE, Vasan RS, Seshadri S (2017). Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study. Alzheimer’s & Dementia, 13(12):1327-1336.
27. Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK, Satizabal CL, Vasan RS, Seshadri S (2017). Non-Alcoholic Fatty Liver Disease is associated with Lower Brain Volume in Healthy Middle-Aged Adults: The Framingham Study. JAMA Neurology, 75(1):97-104.
28. Lutski M, Weinstein G, Goldbourt U, Tanne D (2018). Cardiovascular Health and Cognitive Decline 2 Decades Later in Men with Preexisting Coronary Artery Disease. American Journal of Cardiology, 121(4):410-415.
29. Weinstein G, Lutski M, Goldbourt U, and Tanne D (2018). Physical frailty and cognitive function among men with cardiovascular disease. Archives of Gerontology and Geriatr 78:1-6.
30. Lutski M, Haratz S, Weinstein G, Goldbourt U, Tanne D (2018). Impaired Cerebral Hemodynamics and Frailty in Patients with Cardiovascular Disease. The journals of gerontology. Series A, Biological sciences and medical sciences. 73(12):1714-1721.
31. Weinstein G, Elran Barak R, Beeri MS, Ravona-Springer R (2018). Personality traits and cognitive function in old-adults with type-2 diabetes. Aging and Mental Health. 23(10):1317-1325.
32. Lutski M, Weinstein G, Goldbourt U, Tanne D (2018). Plasma lipids, apolipoproteins, and subsequent cognitive decline in men with coronary heart disease. Journal of Alzheimer’s disease. 67(3):827-837.
33. Elran Barak R, Weinstein G, Beeri MS, Ravona-Springer R (2018). The associations between objective and subjective health among older adults with type 2 diabetes: The role of personality. Journal of Psychosomatic Research. 117:41-47.
34. Weinstein G, Davis-Plourde KL, Conner S, Himali JJ, Beiser AS, Lee A, Rawlings AM, Sedaghat S, Ding J, Moshier E, van Duijn CM, Beeri MS, Selvin E, Ikram MA, Launer LJ, Haan MN, Seshadri S (2019). Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts. PLoS One. 14(2):e0212293.
35. Weinstein G, Davis-Plourde K, Himali JJ, Zelber-Sagi S, Beiser AS, Seshadri S (2019). The Association of Liver Fibrosis Score with Cognitive Performance in Healthy Middle-Aged Adults: The Framingham Study. Liver International. 39(9):1713-1721.
36. Weinstein G, Davis-Plourde K, Beiser AS, Seshadri S (2019). Author response: The Association of Liver Fibrosis Score with Cognitive Performance in Healthy Middle-Aged Adults: The Framingham Study. Liver International (Ahead of Print).
37. Lutski M, Weinstein G, Tanne D, Goldbourt U (2019). Angina pectoris severity and late-life frailty among men with cardiovascular disease. Aging Male. 26:1-8.
38. Weinstein G, Lutski M, Goldbourt U, Tanne D (2019). Midlife resting heart rate, but not its visit-to-visit variability, is associated with late-life frailty status in men with coronary heart disease. Aging Male. 14:1-7. 
39. Lutski M, Weinstein G, Goldbourt U, Tanne D (2020). Adherence to Mediterranean diet and subsequent cognitive decline in men with cardiovascular disease. Nutritional Neuroscience. Ahead of print.
40. Sznitman S, Vulfsons S, Meiri D, Weinstein G (2020). Medical Cannabis and Insomnia in Older Adults with Chronic Pain: a Cross-Sectional Study. BMJ Supportive & Palliative Care. 10(4):415-420.
41. Weinstein G, Sznitman SR. The implications of late-life cannabis use on brain health: A mapping review and implications for future research. Ageing Res Rev. 2020;59:101041.
42. Schwartz E and Weinstein G (2020). Early-life food deprivation and cognitive performance among old-age Europeans. Maturitas. 141:26-32.
43. Vered S, Paz S, Negev M, Tanne D, Zucker I and Weinstein G (2020). High ambient temperature in summer and risk of stroke or transient ischemic attack: A national study in Israel. Environ Res; 187:109678.
44. Kodesh A, Goldberg Y, Rotstein A, Weinstein G, Reichenberg A, Sandin S and Levine SZ (2020). Risk of dementia and death in very-late-onset schizophrenia-like psychosis: A national cohort study. Schizophrenia research. 223:220-226.
45. Sznitman SR, Vulfsons S, Meiri D, and Weinstein G (2020). Medical cannabis and cognitive performance in middle to old adults treated for chronic pain. Drug and Alcohol Review. 40(2):272-280.
46. Shuval K, Sahar L, Gabriel KP, Knell G, Weinstein G, Gafni Gal T, Lobelo F, DiPietro L (2020). Sedentary Behavior, Physical Inactivity, and Metabolic Syndrome: Pilot Findings From the Rapid Assessment Disuse Index Study. J Phys Act Health. 17(10):1042-1046.
47. Li S^$, Weinstein G^$, Zare H, Teumer A, Völker U, Friedrich N, Knol MJ, Satizabal CL, Petyuk VA, Adams HHH, Launer LJ, Bennett DA, De Jager PL, Grabe1 HJ, Ikram MA, Gudnason V, Yang Q and Seshadri S (2020). The genetics of circulating BDNF: towards understanding the role of BDNF in brain aging. Brain Communication. ^$Shared first authorship. 2(2):fcaa176.
48. Lutski M, Weinstein G, Tanne D, Goldbourt U (2020). Overweight, obesity and late-life sarcopenia in men with cardiovascular disease. Preventing Chronic Disease. 17:E164.
49. Weinstein G, Miri Lutski, Lital Keinan-Boker, Uri Goldbourt, and David Tanne (2021). Holocaust exposure and late-life cognitive performance in Men with Coronary Heart Disease. Journal of Psychiatric Research. 134:1-7.
50. Galit Weinstein, Kendra Davis, Alexa Beiser and Sudha Seshadri (2021). Autonomic Imbalance and Risk of Dementia and Stroke: The Framingham Study. Stroke. 52(6):2068-2076.
51. Tal Gafni-Gal, Kerem Shuval, Galit Weinstein, Kelley Pettee Gabriel, Beth Wright, Benjamin L. Willis, MD, David Leonard, William Haskell, Laura DeFina (2021). Independent and Joint Associations of Sitting Time and Physical Activity with Cognition Function among Mid-Life Adults: The Cooper Center Longitudinal Study. Journal of Aging and Physical Activity. 17(10):1042-1046.
52. Galit Weinstein, Ella Cohn-Schwartz and Noam Damri (2021). Book-oriented environment in childhood and current cognitive performance among old-aged Europeans. Dementia and Geriatric Cognitive Disorders. Ahead of print.